Vestal Point Capital, LP

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
63
Total Value
1400316542
Accession Number
0001974915-25-000005
Form Type
13F-HR
Manager Name
Vestal-Point-Capital-Lp
Data Enrichment
97% identified
61 identified2 unidentified

Holdings

63 positions
Manager:
Search and click to pin securities to the top
Page 1 of 4
Arcellx, Inc.
Shares:2.4M
Value:$156.6M
CYTOKINETICS INC
Shares:2.6M
Value:$104.1M
INSMED Inc
Shares:1.1M
Value:$82.0M
Nuvalent, Inc.
Shares:1.1M
Value:$76.2M
Vera Therapeutics, Inc.
Shares:2.5M
Value:$60.0M
KalVista Pharmaceuticals, Inc.
Shares:4.8M
Value:$54.8M
uniQure N.V.
Shares:4.8M
Value:$50.8M
Crinetics Pharmaceuticals, Inc.
Shares:1.5M
Value:$50.3M
Xenon Pharmaceuticals Inc.
Shares:1.3M
Value:$43.6M
Scholar Rock Holding Corp
Shares:1.3M
Value:$41.8M
Bicara Therapeutics Inc.
Shares:2.8M
Value:$36.1M
GERON CORP
Shares:22.0M
Value:$35.0M
AMICUS THERAPEUTICS, INC.
Shares:4.3M
Value:$34.9M
Immatics N.V.
Shares:7.2M
Value:$32.4M
Structure Therapeutics Inc.
Shares:1.8M
Value:$31.0M
Dianthus Therapeutics, Inc. /DE/
Shares:1.7M
Value:$30.8M
Savara Inc
Shares:11.0M
Value:$30.5M
Tyra Biosciences, Inc.
Shares:2.9M
Value:$26.8M
DANAHER CORP /DE/
Shares:125.0K
Value:$25.6M
UroGen Pharma Ltd.
Shares:2.2M
Value:$23.8M